DeLuca Richard R.'s Form 4 filing
Merck & Co., Inc. (MRK) · filed Aug 10, 2026
- Accession no.
- 0000310158-26-000217
- Filed
- Aug 10, 2026, 4:28 PM ET
- Trade date
- Aug 6, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $788.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DeLuca Richard R.CIK 0001421339 | Officer (EVP&Pres, Merck Animal Heallth) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | SSaleDisposed | −805 | $131.02 | −$105,472.39 | 160,732.07 | Direct | |
| Aug 6, 2026 | Common Stock | SSaleDisposed | −4,945 | $130.23 | −$643,993.28 | 155,787.07 | Direct | |
| Aug 6, 2026 | Common Stock | SSaleDisposed | −300 | $131.02 | −$39,306.99 | 155,487.07 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.